Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks

Surinder S Birring; Peter V Dicpinigaitis; Jaclyn A Smith; Alyn H Morice; Lorcan P McGarvey; Ian D Pavord; Allison Martin Nguyen; Jonathan Schelfhout; Qing Li; Beata Iskold; Stuart A Green; George Philip; David R Muccino; Carmen La Rosa

doi:10.1164/rccm.202211-2128LE

Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks

Surinder S Birring^*, Peter V Dicpinigaitis, Jaclyn A Smith, Alyn H Morice, Lorcan P McGarvey, Ian D Pavord, Allison Martin Nguyen, Jonathan Schelfhout, Qing Li, Beata Iskold, Stuart A Green, George Philip, David R Muccino, Carmen La Rosa

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

21 Downloads (Pure)

Original language	English
Journal	American Journal of Respiratory and Critical Care Medicine
Early online date	30 Mar 2023
DOIs	https://doi.org/10.1164/rccm.202211-2128LE
Publication status	Early online date - 30 Mar 2023

Keywords

cough

Access to Document

10.1164/rccm.202211-2128LELicence: Unspecified

Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks
Copyright 2023, American Thoracic Society. This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 295 KBLicence: Unspecified

Cite this

Birring, S. S., Dicpinigaitis, P. V., Smith, J. A., Morice, A. H., McGarvey, L. P., Pavord, I. D., Martin Nguyen, A., Schelfhout, J., Li, Q., Iskold, B., Green, S. A., Philip, G., Muccino, D. R., & La Rosa, C. (2023). Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks. American Journal of Respiratory and Critical Care Medicine. Advance online publication. https://doi.org/10.1164/rccm.202211-2128LE

@article{5aef2e37af274d1b88a6f110966d4e51,

title = "Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks",

keywords = "cough",

author = "Birring, {Surinder S} and Dicpinigaitis, {Peter V} and Smith, {Jaclyn A} and Morice, {Alyn H} and McGarvey, {Lorcan P} and Pavord, {Ian D} and {Martin Nguyen}, Allison and Jonathan Schelfhout and Qing Li and Beata Iskold and Green, {Stuart A} and George Philip and Muccino, {David R} and {La Rosa}, Carmen",

year = "2023",

month = mar,

day = "30",

doi = "10.1164/rccm.202211-2128LE",

language = "English",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

}

Birring, SS, Dicpinigaitis, PV, Smith, JA, Morice, AH, McGarvey, LP, Pavord, ID, Martin Nguyen, A, Schelfhout, J, Li, Q, Iskold, B, Green, SA, Philip, G, Muccino, DR & La Rosa, C 2023, 'Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks', American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.202211-2128LE

TY - JOUR

T1 - Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks

AU - Birring, Surinder S

AU - Dicpinigaitis, Peter V

AU - Smith, Jaclyn A

AU - Morice, Alyn H

AU - McGarvey, Lorcan P

AU - Pavord, Ian D

AU - Martin Nguyen, Allison

AU - Schelfhout, Jonathan

AU - Li, Qing

AU - Iskold, Beata

AU - Green, Stuart A

AU - Philip, George

AU - Muccino, David R

AU - La Rosa, Carmen

PY - 2023/3/30

Y1 - 2023/3/30

KW - cough

U2 - 10.1164/rccm.202211-2128LE

DO - 10.1164/rccm.202211-2128LE

M3 - Article

C2 - 36996347

SN - 1073-449X

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

ER -